download chevron-down chevron-right chevron-with-circle-down chevron-with-circle-up check circle-with-minus circle-with-plus export help-with-circle inbox link mail old-phone star-outlined star user v-card close close close Back to top
Top

Safe Use of Opioids - Concurrent Prescribing*

CMS Measure ID
CMS506v2
Version
2
NQF Number
3316e
Measure Description

Proportion of inpatient hospitalizations for patients 18 years of age and older prescribed, or continued on, two or more opioids or an opioid and benzodiazepine concurrently at discharge

Initial Population

Inpatient hospitalizations (inpatient stay less than or equal to 120 days) that end during the measurement period, where the patient is 18 years of age and older at the start of the encounter and prescribed a new or continuing opioid or benzodiazepine at discharge

Denominator Statement
Denominator Exclusions

Inpatient hospitalizations where patients have cancer that overlaps the encounter or are receiving palliative or hospice care (including comfort measures, terminal care, and dying care) during the encounter

Numerator Statement

Inpatient hospitalizations where the patient is prescribed or continuing to take two or more opioids or an opioid and benzodiazepine at discharge

Numerator Exclusions

Not Applicable

Denominator Exceptions

None

Measure Scoring
Measure Type
Improvement Notation

Improvement noted as a decrease in the rate

Guidance

Clinician judgement, clinical appropriateness, or both may indicate concurrent prescribing of two unique opioids or an opioid and benzodiazepine is medically necessary, thus the measure is not expected to have a zero rate. 

Inpatient hospitalizations with discharge medications of a new or continuing opioid or a new or continuing benzodiazepine prescription should be included in the initial population

Inpatient hospitalizations with discharge medications of two or more new or continuing opioids or new or continuing opioid and benzodiazepine resulting in concurrent therapy at discharge should be included in the numerator.

Notes

Pre-rulemaking

*CMS updated the specification for CMS506, Safe Use of Opioids – Concurrent Prescribing to restrict the measure population to inpatient encounters. The eCQM Version Number was incremented from v1.3.000 to v2.0.

Specifications

Attachment Size
CMS506v2.html 63.05 KB
CMS506v2.zip 60.15 KB
Last Updated: Oct 10, 2019